Skye Bioscience Inc (SKYE)
5.53
+0.21
(+3.95%)
USD |
NASDAQ |
Nov 14, 16:00
5.53
0.00 (0.00%)
After-Hours: 20:00
Skye Bioscience Price: 5.53 for Nov. 14, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2024 | 5.49 | 5.51 | 5.16 | 5.32 | 117068.0 |
| Nov 12, 2024 | 5.49 | 5.558 | 5.30 | 5.39 | 79880.00 |
| Nov 11, 2024 | 5.86 | 5.90 | 5.460 | 5.50 | 148765.0 |
| Nov 08, 2024 | 5.96 | 5.96 | 5.44 | 5.71 | 159133.0 |
| Nov 07, 2024 | 5.41 | 5.83 | 5.315 | 5.44 | 192734.0 |
| Nov 06, 2024 | 5.43 | 5.60 | 5.01 | 5.37 | 216760.0 |
| Nov 05, 2024 | 5.74 | 5.74 | 4.97 | 5.35 | 185238.0 |
| Nov 04, 2024 | 5.80 | 5.90 | 5.12 | 5.44 | 236718.0 |
| Nov 01, 2024 | 5.31 | 5.57 | 5.25 | 5.56 | 93959.00 |
| Oct 31, 2024 | 5.12 | 5.28 | 4.92 | 5.24 | 111478.0 |
| Oct 30, 2024 | 5.20 | 5.20 | 4.90 | 5.09 | 171435.0 |
| Oct 29, 2024 | 5.05 | 5.22 | 4.90 | 5.22 | 176728.0 |
| Oct 28, 2024 | 5.14 | 5.16 | 4.96 | 5.15 | 102820.0 |
| Oct 25, 2024 | 4.88 | 5.05 | 4.785 | 5.03 | 128207.0 |
| Oct 24, 2024 | 5.25 | 5.29 | 4.65 | 4.88 | 344911.0 |
| Oct 23, 2024 | 4.94 | 5.20 | 4.795 | 5.20 | 168092.0 |
| Oct 22, 2024 | 4.75 | 4.95 | 4.530 | 4.94 | 229369.0 |
| Oct 21, 2024 | 4.80 | 5.48 | 4.50 | 4.71 | 530608.0 |
| Oct 18, 2024 | 4.24 | 4.63 | 4.006 | 4.63 | 289774.0 |
| Oct 17, 2024 | 4.29 | 4.48 | 4.015 | 4.23 | 162371.0 |
| Oct 16, 2024 | 4.23 | 4.43 | 4.110 | 4.28 | 302290.0 |
| Oct 15, 2024 | 4.05 | 4.525 | 4.02 | 4.20 | 408871.0 |
| Oct 14, 2024 | 4.34 | 4.40 | 3.76 | 4.09 | 360719.0 |
| Oct 11, 2024 | 3.75 | 4.30 | 3.74 | 4.29 | 229591.0 |
| Oct 10, 2024 | 3.66 | 3.75 | 3.53 | 3.74 | 199447.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.44
Minimum
Nov 15 2023
78.42
Maximum
Nov 20 2019
14.86
Average
9.75
Median
Oct 02 2020
Price Benchmarks
| Oramed Pharmaceuticals Inc | 2.33 |
| Viking Therapeutics Inc | 53.68 |
| NovaBay Pharmaceuticals Inc | 0.7276 |
| Palatin Technologies Inc | 1.07 |
| iBio Inc | 2.18 |
Price Related Metrics
| PS Ratio | 561.37 |
| Price to Book Value | 2.213 |
| Earnings Yield | -15.15% |
| Market Cap | 167.77M |